MitoChem Therapeutics, Inc.
Biotechnology company · Charleston, South Carolina, United States
MitoChem Therapeutics, Inc. is a biotechnology company headquartered in Charleston, South Carolina, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $233,491 in total, most recently in 2012. It has reported private securities offerings to the US SEC, most recently $235,766 sold in a notice filed in 2020.
MitoChem Therapeutics at a glance
What does MitoChem Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $233,491 in total (2012).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $235,766 sold (2020).
Frequently asked questions about MitoChem Therapeutics
Where is MitoChem Therapeutics headquartered?
MitoChem Therapeutics, Inc. is headquartered in Charleston, South Carolina, United States.
What does MitoChem Therapeutics do?
MitoChem Therapeutics, Inc. is a biotechnology company.
Similar companies
- Tissue Testing Technologies LLCCharleston, South Carolina, United States
- Fibrotherapeutics IncCharleston, South Carolina, United States
- FibroBiologics, LLCCharleston, South Carolina, United States
- Loxigen, Inc.Charleston, South Carolina, United States
- Lydex Pharmaceuticals LLCCharleston, South Carolina, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences